{"title":"REST/NRSF Regulation of Epilepsy and Cognitive Impairment: Mechanisms and EEG Correlations.","authors":"Liang OUyang, Xiao-Xuan Li, Bing Li","doi":"10.1007/s12035-025-05138-3","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to investigate the relationship between REST/NRSF and cognitive impairment in epilepsy, focusing on EEG alterations and serum REST/NRSF levels as potential biomarkers. Additionally, the study explored how REST/NRSF regulation in the hippocampus affects epileptic activity and cognitive function through the modulation of Kv7.2/7.3 potassium channels. We studied 50 epilepsy patients (25 with cognitive impairment, 25 without) and 40 healthy controls. High-density EEG was used to assess brain activity across various frequency bands. Serum REST/NRSF levels were measured by ELISA and correlated with cognitive performance (MoCA). ROC analysis and logistic regression assessed the predictive value of EEG and REST/NRSF for cognitive dysfunction. In animal models, KA-induced epileptic mice were used to study REST/NRSF expression and its effect on Kv7.2/7.3 channels through Western blotting and qRT-PCR. The δ relative power and DTABR in the left frontoparietal, left frontotemporal, and left temporal regions of the epilepsy cognitive impairment group were significantly higher than those of the non-cognitive impairment and control groups (P < 0.05); conversely, the α relative power in the same regions was significantly lower (P < 0.05). Serum REST/NRSF levels were significantly higher in the cognitive impairment group and negatively correlated with cognitive function (P < 0.05). ROC curve analysis revealed high predictive value for δ and α frequency band power and serum REST/NRSF levels for cognitive dysfunction in epilepsy (AUC > 0.8). In KA model mice, REST/NRSF protein levels were significantly elevated in the hippocampal CA1 region, while Kv7.2/7.3 expression was reduced. Knockdown of REST/NRSF in the hippocampus resulted in reduced seizure severity, while overexpression of REST/NRSF exacerbated seizures. This study demonstrates that cognitive impairment in epilepsy is linked to changes in EEG power spectra and elevated serum REST/NRSF levels. These findings suggest that REST/NRSF plays a role in regulating both epileptic activity and cognitive dysfunction, potentially through modulation of Kv7.2/7.3 potassium channels. These results highlight REST/NRSF as a promising biomarker and therapeutic target for cognitive impairment in epilepsy.</p>","PeriodicalId":18762,"journal":{"name":"Molecular Neurobiology","volume":" ","pages":"14176-14195"},"PeriodicalIF":4.3000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Neurobiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12035-025-05138-3","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
This study aimed to investigate the relationship between REST/NRSF and cognitive impairment in epilepsy, focusing on EEG alterations and serum REST/NRSF levels as potential biomarkers. Additionally, the study explored how REST/NRSF regulation in the hippocampus affects epileptic activity and cognitive function through the modulation of Kv7.2/7.3 potassium channels. We studied 50 epilepsy patients (25 with cognitive impairment, 25 without) and 40 healthy controls. High-density EEG was used to assess brain activity across various frequency bands. Serum REST/NRSF levels were measured by ELISA and correlated with cognitive performance (MoCA). ROC analysis and logistic regression assessed the predictive value of EEG and REST/NRSF for cognitive dysfunction. In animal models, KA-induced epileptic mice were used to study REST/NRSF expression and its effect on Kv7.2/7.3 channels through Western blotting and qRT-PCR. The δ relative power and DTABR in the left frontoparietal, left frontotemporal, and left temporal regions of the epilepsy cognitive impairment group were significantly higher than those of the non-cognitive impairment and control groups (P < 0.05); conversely, the α relative power in the same regions was significantly lower (P < 0.05). Serum REST/NRSF levels were significantly higher in the cognitive impairment group and negatively correlated with cognitive function (P < 0.05). ROC curve analysis revealed high predictive value for δ and α frequency band power and serum REST/NRSF levels for cognitive dysfunction in epilepsy (AUC > 0.8). In KA model mice, REST/NRSF protein levels were significantly elevated in the hippocampal CA1 region, while Kv7.2/7.3 expression was reduced. Knockdown of REST/NRSF in the hippocampus resulted in reduced seizure severity, while overexpression of REST/NRSF exacerbated seizures. This study demonstrates that cognitive impairment in epilepsy is linked to changes in EEG power spectra and elevated serum REST/NRSF levels. These findings suggest that REST/NRSF plays a role in regulating both epileptic activity and cognitive dysfunction, potentially through modulation of Kv7.2/7.3 potassium channels. These results highlight REST/NRSF as a promising biomarker and therapeutic target for cognitive impairment in epilepsy.
期刊介绍:
Molecular Neurobiology is an exciting journal for neuroscientists needing to stay in close touch with progress at the forefront of molecular brain research today. It is an especially important periodical for graduate students and "postdocs," specifically designed to synthesize and critically assess research trends for all neuroscientists hoping to stay active at the cutting edge of this dramatically developing area. This journal has proven to be crucial in departmental libraries, serving as essential reading for every committed neuroscientist who is striving to keep abreast of all rapid developments in a forefront field. Most recent significant advances in experimental and clinical neuroscience have been occurring at the molecular level. Until now, there has been no journal devoted to looking closely at this fragmented literature in a critical, coherent fashion. Each submission is thoroughly analyzed by scientists and clinicians internationally renowned for their special competence in the areas treated.